MENTEŞOĞLU, D. Et Al. 2022. Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab. INDIAN JOURNAL OF PHARMACOLOGY , vol.54, no.4 , 295-296.

MENTEŞOĞLU, D., DOĞAN GÜNAYDIN, S., ERSOY EVANS, S., Atakan, N., GÖKÖZ, Ö., KARADAĞ, Ö., ... KILIÇKAP, S.(2022). Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab. INDIAN JOURNAL OF PHARMACOLOGY , vol.54, no.4, 295-296.

MENTEŞOĞLU, DİLEK Et Al. "Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab," INDIAN JOURNAL OF PHARMACOLOGY , vol.54, no.4, 295-296, 2022

MENTEŞOĞLU, DİLEK Et Al. "Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab." INDIAN JOURNAL OF PHARMACOLOGY , vol.54, no.4, pp.295-296, 2022

MENTEŞOĞLU, D. Et Al. (2022) . "Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab." INDIAN JOURNAL OF PHARMACOLOGY , vol.54, no.4, pp.295-296.

@article{article, author={DİLEK MENTEŞOĞLU Et Al. }, title={Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab}, journal={INDIAN JOURNAL OF PHARMACOLOGY}, year=2022, pages={295-296} }